Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFD Technologies Regulatory News (FDP)

  • This share is currently suspended. It was suspended at a price of 2,450.00
  • There is currently no data for FDP

Directorate Change

10 Dec 2012 07:00

RNS Number : 0918T
First Derivatives PLC
10 December 2012
 



First Derivatives plc

("First Derivatives" or the "Company")

 

Directorate Change

 

First Derivatives plc (AIM: FDP.L, ESM: GYQ.I), a leading provider of software and consulting services to the capital markets industry, is pleased to announce the appointment of Seamus Keating as a Non Executive Director of the Company.

 

Seamus has over twenty years experience in the global technology sector in both finance and operational roles and was a main board director of Logica plc from 2002 until April 2012. He was Logica Group CFO until 2010 when he became COO and head of its Benelux operations. He also chaired the group's worldwide Financial Services practice. Having implemented a major restructuring plan in the Benelux region, he resigned from Logica plc, ahead of its acquisition by CGI of Canada. Prior to his role at Logica, he worked for the Olivetti Group in finance roles in the UK and Italy. He is currently working in the mid market private equity technology sector.

 

Seamus joined the board of Mouchel Group plc and became chair of the audit committee in November 2010, following a number of profit warnings, and remained on the board until September 2012, when the company was restructured and placed into Administration and its business purchased by a buyout company owned by its lenders.

 

Brian Conlon, CEO of First Derivatives, commented; "I am delighted to welcome a Director of Seamus' pedigree to the Board. His wide ranging experience with world class technology businesses in our sector will provide valuable insights as we expand the size and the breadth of our business."

 

Details of directorships that Seamus Declan Keating, aged 49, holds, or has held in the previous five years, are given below:

 

Current directorships:

Skapital Limited

 

Past directorships:

Logica PLC

Mouchel Group plc

 

Save for the declarations above there is no further information to be disclosed under Rule 17 or Schedule Two paragraph (g) of the AIM Rules for Companies.

 

 

Enquiries:

 

First Derivatives plc

+44(0)28 3025 2242

Brian Conlon, Chief Executive

www.firstderivatives.com

Graham Ferguson, Chief Financial Officer

Charles Stanley SecuritiesNominated Adviser and Broker

+44 (0)20 7149 6000

Russell Cook

Carl Holmes

Goodbody Corporate FinanceESM Adviser and Broker

+353 1 667 0420

Diane Hodgson

Linda Hickey

Walbrook PR

+44 (0)20 7933 8780

Bob Huxford

bob.huxford@walbrookpr.com

Paul Cornelius

paul.cornelius@walbrookir.com

Stakeholder Communications

+44 (0) 2890 339949

Jonathan King

John Hart

 

 

About First Derivatives

 

First Derivatives is a global provider of software and consulting services to the financial services industry. With over 15 years experience working with leading financial institutions, it continues to deliver technologically advanced, award winning products and services that anticipate and respond to the evolving needs of global capital markets.

 

First Derivatives currently employs over 710 people worldwide and counts many of the world's top investment banks, brokers and hedge funds as its customers. It has operations in London, New York, Stockholm, Shanghai, Singapore, Toronto, Sydney, Dublin, Newry and Hong Kong.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOALKLLBLLFEFBX
Date   Source Headline
11th Feb 20144:18 pmRNSDirector's Shareholding
10th Feb 20147:00 amRNSIssue of Equity
6th Feb 20147:00 amRNSOpening of Singapore Office
20th Jan 20147:00 amRNSDirector/PDMR Shareholding
31st Dec 201311:08 amRNSTotal Voting Rights
20th Dec 20134:33 pmRNSIssue of Equity
5th Dec 20137:00 amRNSEnterprise Securities Market Notice
29th Nov 20134:00 pmRNSIssue of Equity
26th Nov 20137:00 amRNSASIC goes live with new surveillance system
5th Nov 20137:00 amRNSInterim Results
23rd Oct 20137:00 amRNSNotice of Results
30th Sep 20131:34 pmRNSTotal Voting Rights
18th Sep 20131:01 pmRNSCollaboration with NYSE Technologies
11th Sep 20137:00 amRNSEnterprise Securities Market Notice
10th Sep 20137:00 amRNSContract Win
5th Sep 20132:41 pmRNSIssue of Equity
30th Aug 20131:05 pmRNSTotal Voting Rights
21st Aug 20137:00 amRNSDelta Stream Selected by Communications Provider
14th Aug 20137:00 amRNSEnterprise Securities Market Notice
8th Aug 201312:53 pmRNSIssue of Equity
18th Jul 201312:55 pmRNSResult of AGM
9th Jul 20137:00 amRNSEnterprise Securities Market Notice
5th Jul 20134:11 pmRNSHolding(s) in Company
5th Jul 20134:10 pmRNSHolding(s) in Company
3rd Jul 20133:18 pmRNSIssue of Equity
3rd Jul 20137:00 amRNSEnterprise Securities Market Notice
28th Jun 20137:00 amRNSPlacing of 840,000 new ordinary shares
18th Jun 20137:00 amRNSFinal Results
5th Jun 20137:00 amRNSNotice of Results
9th May 20137:00 amRNSBoard restructuring
30th Apr 20138:00 amRNSTotal Voting Rights
26th Apr 20133:54 pmRNSEnterprise Securities Market Notice
23rd Apr 20137:00 amRNSEnterprise Securities Market Notice
19th Apr 20137:30 amRNSChange in Directors Shareholding
19th Apr 20137:30 amRNSGrant of Options
17th Apr 20133:10 pmRNSIssue of Equity
3rd Apr 20133:40 pmRNSDirector's Shareholding
2nd Apr 20137:00 amRNSPre-close period trading update
15th Mar 20137:00 amRNSSEF initiative & Compliance Officer appointment
28th Feb 20137:00 amRNSTotal Voting Rights
11th Feb 20137:00 amRNSEnterprise Securities Market Notice
6th Feb 20137:00 amRNSExercise of Options
4th Jan 20133:41 pmRNSDirector/PDMR Shareholding
13th Dec 20127:00 amRNSContract win
10th Dec 20127:00 amRNSDirectorate Change
30th Nov 20127:00 amRNSTotal Voting Rights
16th Nov 20127:00 amRNSEnterprise Securities Market Notice
14th Nov 20127:00 amRNSDirector shareholding
13th Nov 20127:00 amRNSDirector shareholding
12th Nov 20123:24 pmRNSExercise of Options

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.